HIV Infections Clinical Trials

A listing of HIV Infections medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35294

A Phase 4 clinical study for patients with HIV Infections or Cardiovascular Diseases

Birmingham Alabama 35294

A clinical trial seeking patients for a research study for the MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection

Birmingham Alabama 35233

A Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines

Arizona

UPDATED

Phoenix Arizona 85015

Patients are needed to participate in a clinical research study evaluating MK-1439A and ATRIPLA™ for the treatment of Human Immunodeficiency Virus (HIV) (MK-14391-021)

UPDATED

Phoenix Arizona 85015

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

Phoenix Arizona

A clinical trial to evaluate treatments using D/C/F/TAF, Boosted Protease Inhibitor (bPI) and FTC/TDF for patients with Human Immunodeficiency Virus Type 1

Arkansas

UPDATED

Little Rock Arkansas 72207-6365

Patients are needed to participate in a clinical research study evaluating MK-1439A and ATRIPLA™ for the treatment of Human Immunodeficiency Virus (HIV) (MK-14391-021)

UPDATED

Little Rock Arkansas 72207

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

Little Rock Arkansas 72207

A clinical trial seeking patients for a research study for the MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection

California

UPDATED

Bakersfield California 93301

Patients are needed to participate in a clinical research study evaluating MK-1439A and ATRIPLA™ for the treatment of Human Immunodeficiency Virus (HIV) (MK-14391-021)

UPDATED

Beverly Hills California 90211

Patients are needed to participate in a clinical research study evaluating MK-1439A and ATRIPLA™ for the treatment of Human Immunodeficiency Virus (HIV) (MK-14391-021)

UPDATED

Beverly Hills California 90211

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

UPDATED

Los Angeles California 90033-1079

A Phase 4 clinical study for patients with HIV Infections or Cardiovascular Diseases

UPDATED

Los Angeles California 90073

A Phase 4 clinical study for patients with HIV Infections or Cardiovascular Diseases

View More ▼

UPDATED

Los Angeles California 90232

A Phase 4 clinical study for patients with HIV Infections or Cardiovascular Diseases

UPDATED

Los Angeles California 90035

A Phase 4 clinical study for patients with HIV Infections or Cardiovascular Diseases

UPDATED

Los Angeles California 90036

Patients are needed to participate in a clinical research study evaluating MK-1439A and ATRIPLA™ for the treatment of Human Immunodeficiency Virus (HIV) (MK-14391-021)

UPDATED

Los Angeles California 90027

Patients are needed to participate in a clinical research study evaluating MK-1439A and ATRIPLA™ for the treatment of Human Immunodeficiency Virus (HIV) (MK-14391-021)

UPDATED

Los Angeles California 90036

Patients are needed to participate in a clinical research study evaluating MK-1439A for the treatment of HIV-1 Infection (MK-1439A-030)

UPDATED

Los Angeles California 90036

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

UPDATED

Los Angeles California 90027

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

UPDATED

Los Angeles California 90035

Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection

UPDATED

Palm Springs California 92262

Patients are needed to participate in a clinical research study evaluating MK-1439A and ATRIPLA™ for the treatment of Human Immunodeficiency Virus (HIV) (MK-14391-021)

UPDATED

Palo Alto California 94304-5350

A Phase 4 clinical study for patients with HIV Infections or Cardiovascular Diseases

UPDATED

Rialto California 92377

Patients are needed to participate in a clinical research study evaluating MK-1439A and ATRIPLA™ for the treatment of Human Immunodeficiency Virus (HIV) (MK-14391-021)

UPDATED

Rialto California 92377

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

UPDATED

Sacramento California 95811

Patients are needed to participate in a clinical research study evaluating MK-1439A and ATRIPLA™ for the treatment of Human Immunodeficiency Virus (HIV) (MK-14391-021)

UPDATED

Sacramento California 95811

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

UPDATED

Sacramento California 95825

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

UPDATED

San Diego California 92103

A Phase 4 clinical study for patients with HIV Infections or Cardiovascular Diseases

UPDATED

San Francisco California 94110

A Phase 4 clinical study for patients with HIV Infections or Cardiovascular Diseases

UPDATED

San Francisco California 94115

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

UPDATED

San Francisco California 94118

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

UPDATED

San Leandro California 94577

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

UPDATED

Torrance California 90502

A Phase 4 clinical study for patients with HIV Infections or Cardiovascular Diseases

Bakersfield California

A clinical trial to evaluate treatments using D/C/F/TAF, Boosted Protease Inhibitor (bPI) and FTC/TDF for patients with Human Immunodeficiency Virus Type 1

Beverly Hills California

A clinical trial to evaluate treatments using D/C/F/TAF, Boosted Protease Inhibitor (bPI) and FTC/TDF for patients with Human Immunodeficiency Virus Type 1

Glendale California 91206

Patients are needed to participate in a clinical research study of ABC/DTG/3TC FDC tablet to evaluate Infection, Human Immunodeficiency Virus

Long Beach California 90806

A clinical research study of ATV, DRV, Cobicistat and Background regimen for the treatment of Acquired Immune Deficiency Syndrome (AIDS) or HIV Infections

Long Beach California

A clinical trial to evaluate treatments using D/C/F/TAF, Boosted Protease Inhibitor (bPI) and FTC/TDF for patients with Human Immunodeficiency Virus Type 1

Long Beach California 90813

A clinical trial to evaluate treatments using SB-728mR-T and Cyclophosphamide for patients with Human Immunodeficiency Virus (HIV)

Long Beach California 90806

A Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines

Long Beach California 08275

Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Participants

Los Angeles California 90027

A clinical research study of ATV, DRV, Cobicistat and Background regimen for the treatment of Acquired Immune Deficiency Syndrome (AIDS) or HIV Infections

Los Angeles California

A clinical trial to evaluate treatments using D/C/F/TAF, Boosted Protease Inhibitor (bPI) and FTC/TDF for patients with Human Immunodeficiency Virus Type 1

Los Angeles California 90069

A clinical trial to evaluate treatments using SB-728mR-HSPC Infusion 3 days following busulfan conditioning for patients with HIV

Los Angeles California 90095

A Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines

Los Angeles California 90054

A Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines

Los Angeles California 90033

A Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines

Los Angeles California 90027

Patients are needed to participate in a clinical research study evaluating Investigational BD FACS Presto System, BD FACSCalibur flow cytometer and Sysmex hematology analyzer KX-21 for the treatment of Acquired Immunodeficiency Syndrome